Holen Sie sich die Stockscreener-App
39.25
1.37%
0.53
Handel nachbörslich:
38.79
-0.46
-1.17%
Schlusskurs vom Vortag:
$38.72
Offen:
$38.66
24-Stunden-Volumen:
59,073
Relative Volume:
0.53
Marktkapitalisierung:
$549.28M
Einnahmen:
$138.20M
Nettoeinkommen (Verlust:
$5.52M
KGV:
-23.79
EPS:
-1.65
Netto-Cashflow:
$9.86M
1W Leistung:
+2.00%
1M Leistung:
+2.59%
6M Leistung:
+13.37%
1J Leistung:
+11.86%
1-Tages-Spanne:
$38.29
$39.26
1-Wochen-Bereich:
$37.86
$39.26
52-Wochen-Spanne:
$25.17
$42.44
Surmodics Inc Stock (SRDX) Company Profile
Firmenname
Surmodics Inc
Sektor
Branche
Telefon
(952) 500-7000
Adresse
9924 W 74TH ST, EDEN PRAIRIE, MN
Vergleichen Sie SRDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| SRDX | 39.25 | 549.28M | 138.20M | 5.52M | 9.86M | -1.65 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-13 | Hochstufung | Needham | Hold → Buy |
| 2023-02-13 | Herabstufung | Needham | Buy → Hold |
| 2020-07-23 | Hochstufung | Needham | Hold → Buy |
| 2019-12-11 | Herabstufung | Needham | Buy → Hold |
| 2019-11-01 | Herabstufung | Lake Street | Buy → Hold |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Lake Street | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-02-21 | Bestätigt | Needham | Buy |
| 2018-05-16 | Bestätigt | Needham | Buy |
| 2018-03-01 | Hochstufung | Sidoti | Neutral → Buy |
| 2018-02-28 | Bestätigt | Lake Street | Buy |
| 2018-02-28 | Eingeleitet | Needham | Buy |
| 2017-07-14 | Eingeleitet | Lake Street | Buy |
| 2016-11-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-10-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-05-03 | Bestätigt | Barrington Research | Outperform |
| 2015-08-06 | Bestätigt | Barrington Research | Outperform |
| 2015-03-27 | Eingeleitet | Dougherty & Company | Buy |
| 2014-02-25 | Eingeleitet | Laidlaw | Buy |
| 2013-08-01 | Hochstufung | Feltl & Co. | Buy → Strong Buy |
| 2012-11-12 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Surmodics Inc Aktie (SRDX) Neueste Nachrichten
Surmodics (NASDAQ:SRDX) Now Covered by Analysts at StockNews.com - MarketBeat
The Gory Details on SurModics's Double Miss - AOL
Surmodics Q4 Earnings and Revenues Beat Estimates, Margin Down - MSN
SurModics (SRDX) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Surmodics FY2026 EPS Forecast Lifted by Barrington Research - MarketBeat
Nisa Investment Advisors LLC Sells 67,336 Shares of Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Barrington Research Predicts Higher Earnings for Surmodics - MarketBeat
SurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates - MSN
48,591 Shares in Surmodics, Inc. (NASDAQ:SRDX) Bought by Olympiad Research LP - MarketBeat
Needham & Company LLC Reiterates "Hold" Rating for Surmodics (NASDAQ:SRDX) - MarketBeat
Surmodics revenue jumps 19% to USD 33.2M in Q4 2024 - Medical Buyer
Surmodics (NASDAQ:SRDX) Shares Cross Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Surmodics (NASDAQ:SRDX) Now Covered by StockNews.com - Defense World
Surmodics (NASDAQ:SRDX) Coverage Initiated at StockNews.com - MarketBeat
Surmodics Inc. Reports Q4 and FY 2024 Results - TipRanks
Morgan Stanley's Strategic Reduction in Surmodics Inc Holdings - GuruFocus.com
Surmodics reports Q4 EPS (13c), consensus (29c) - TipRanks
SurModics: Fiscal Q4 Earnings Snapshot - San Antonio Express-News
Surmodics Q4 Revenue Surges 19% YoY, Agrees to $627M GTCR Acquisition Deal | SRDX Stock News - StockTitan
Surmodics reports high success in limb ischemia study By Investing.com - Investing.com Australia
Surmodics reports high success in limb ischemia study - Investing.com India
Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System - Business Wire
When (SRDX) Moves Investors should Listen - Stock Traders Daily
Medical Coatings Market to Grow by USD 5.07 Billion from 2024-2028, Driven by Geriatric Population Growth and AI-Redefining the Market LandscapeTechnavio - Yahoo Finance Australia
Surmodics, Inc. (NASDAQ:SRDX) Shares Sold by Millennium Management LLC - MarketBeat
Surmodics (NASDAQ:SRDX) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Surmodics, Inc. to Post FY2025 Earnings of $0.13 Per Share, Zacks Research Forecasts (NASDAQ:SRDX) - MarketBeat
AQR Capital Management LLC Reduces Holdings in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Trend Tracker for (SRDX) - Stock Traders Daily
Algert Global LLC Makes New $577,000 Investment in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics (NASDAQ:SRDX) Coverage Initiated by Analysts at StockNews.com - MarketBeat
SRDX Stock Down Despite FDA Clearance for Pounce XL System - MSN
Biocompatible Coating Market to Reach $41.4 Billion, Globally, by 2033 at 12% CAGR: Allied Market Research - GlobeNewswire Inc.
FDA clears Surmodics’ Pounce XL thrombectomy system - Mass Device
FDA clears Surmodics' expanded thrombectomy system - Investing.com India
Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter - BioSpace
Water Island Capital LLC Makes New $1.16 Million Investment in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Medical Grade Coatings Market Size Research Report 2032 - WICZ
Surmodics, Inc. (NASDAQ:SRDX) Shares Sold by Disciplined Growth Investors Inc. MN - MarketBeat
Surmodics, Inc. (NASDAQ:SRDX) Short Interest Down 25.3% in September - MarketBeat
(SRDX) Trading Advice - Stock Traders Daily
Solar Stock Under Rs 50: Microcap Company Secures Rs 189 Crore Order, Stock Hits Upper Circuit – Complete Details Inside! - Dalal Street Investment Journal
Views of Wall Street’s Leading Experts on Summit Materials Inc - SETE News
Here's why Sumit Gupta is bullish on diagnostic sector - The Economic Times
Sagefield Capital LP Takes $2.35 Million Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Summit Materials, Inc. (NYSE:SUM) Shares Sold by State of New Jersey Common Pension Fund D - Defense World
Scilex (NASDAQ:SCLX) and Prime Medicine (NYSE:PRME) Critical Analysis - Defense World
Dimensional Fund Advisors LP Cuts Position in Sterling Infrastructure, Inc. (NASDAQ:STRL) - Defense World
Dimensional Fund Advisors LP Cuts Stock Holdings in Summit Materials, Inc. (NYSE:SUM) - Defense World
Finanzdaten der Surmodics Inc-Aktie (SRDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):